Prof. Wang's Group Reveal that Bile Acids Control Metabolic Syndrome through the Inhibition of NLRP3

2016-10-10   |  

Over the past few years, ideas about bile acids have evolved from their being seen as simple lipid solubilizers to complex metabolic integrators. Recently, synthetic agonists of the bile acid receptors have been developed to serve as next-generation drugs for the treatment of metabolic disorders and inflammatory diseases.